City Hill Ventures
Contact Us  
Home About Us Team News
 
   
 

News and Events

Ignyta and Nerviano Announce License Agreement for Two First-in-Class Kinase Inhibitors

8.4.14 press release

 
 
 
   
 
© 2010 City Hill Ventures, LLC Home    About Us    Team    Portfolio    News    Contact Us
 
Learn More